Updates in the new edition:

• Clinical perspective sections that include place of therapy discussions and recommendations from therapeutic guidelines
• Expanded coverage of specialty medications used to treat a variety of complex, chronic conditions that often require special handling and administration and may require careful oversight to manage severe adverse effects and dosage adjustments
• Contemporary topics such as new RSV treatments and vaccines, safety issues associated with the glucagon-like peptide 1 (GLP-1) agonists, novel orphan drugs, biosimilars, and more
• Expanded content on new and emerging gene therapies
• Updates to a variety of vaccine monographs including the pneumococcal, rabies, and respiratory syncytial virus vaccines
• Expanded content on off-label uses and long-term clinical data
• MedWatch alerts, Standardize4Safety information, REMS data, and focused FDA updates for various medications
• New content on over 175 new molecular entities (NMEs) or new therapeutic biological products and substantive revisions on approximately 190 medications